Nearly six years after being diagnosed with stage IV colon cancer, disaster psychologist Jamie Aten is still learning new ways of coping with the trauma stemming from his diagnosis and treatment.

by Jamie Aten

A study indicates that the majority of patients using immune checkpoint inhibitors experience side effects, and radiation oncologists say that requirements for prior authorization are impeding care.

by Kate Yandell

Clinical health psychologist Jamie Ostroff discusses how feelings of blame surrounding a lung cancer diagnosis affect physical and mental health.

by Jen Tota McGivney

The CRISPR gene-editing technique is used for the first time in a U.S. cancer clinical trial, and a new targeted therapy is approved for advanced bladder cancer.

by Kate Yandell

A proposed federal rule says that patients must be informed after mammograms if they have dense breasts.

by Carly Weeks

Cancer patients report difficulty getting student loans deferred, and new guidelines for breast cancer screening are released.

by Kate Yandell

People with metastatic cancer call for more research into survivorship issues facing this group, and a study indicates that taking probiotics may interfere with immunotherapy response.

by Marci A. Landsmann and Kate Yandell

Drugs that target DNA repair enzymes may provide alternatives to long-term chemotherapy for some patients with pancreatic cancer.

by Kate Yandell

Survivors and advocates display their posters alongside the work of thousands of cancer researchers.

by Kevin McLaughlin

Drug developers behind currently approved checkpoint inhibitors discuss the pros and cons of competition in the field.

by Kate Yandell